[Treatment of parkinsonism].
D000547:Amantadine / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000378:metabolism / Q000628:therapy*; D013788:Thalamus / Q000601:surgery*
D000978:Antiparkinson Agents; D004338:Drug Combinations; D010276:Parasympatholytics; D007980:Levodopa; D000547:Amantadine; D002262:Carboxy-Lyases
Behandling av parkinsonisme